Known as "the silent killer" due to its lack of symptoms and reliable screening tests, ovarian cancer remains one of the deadliest gynecologic cancers, claiming more than 12,000 lives annually.

CHICAGO -- Upfront surgery for advanced ovarian cancer failed to improve overall survival (OS) versus interval debulking but did improve progression-free survival (PFS) for the first time in a phase ...

BOSTON — Patients with non-BRCA gene mutations undergoing risk-reduction surgery to prevent tubo-ovarian cancers showed no signs of tubo-ovarian high-grade serous carcinoma or serous tubal ...

Obesity is associated with increased surgical complications in EOC, including wound infections and intestinal problems, but not with overall survival differences. Meta-analysis showed obesity linked ...

Atezolizumab versus placebo in combination with bevacizumab and non-platinum-based chemotherapy in recurrent ovarian cancer: Final overall and progression-free survival results from the AGO-OVAR ...

Comprehensive Genomic Profiling for Resectable Pancreatic Cancer: The Earlier the Better? Data from CHIVA randomized phase II trial (ClinicalTrials.gov identifier: NCT01583322) and Policlinico Gemelli ...

HONOLULU — High-risk women who undergo prophylactic surgery to reduce ovarian cancer risk have few lingering worries about developing cancer in the future or regrets about their decision to undergo ...

Vague is a word frequently used to describe symptoms of ovarian cancer. However, if there are key and persistent signs that last more than two or three weeks, it likely would be wise to see a ...

Eligible patients can receive up to 70 per cent in subsidies for genetic tests, while MediShield Life coverage will be extended to selected risk-reducing surgical procedures.